Brain Irradiation and Tremelimumab in Metastatic Breast Cancer

NCT02563925 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

RADIATION: Brain radiotherapy or Stereotactic Radiosurgery
DRUG: Tremelimumab
DRUG: HER2 directed therapy
DRUG: Durvalumab

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]